Zobrazeno 1 - 10
of 124
pro vyhledávání: '"Liangyou Gu"'
Autor:
Shuo Tian, Songliang Du, Chenfeng Wang, Yu Zhang, Hanfeng Wang, Yang Fan, Yu Gao, Liangyou Gu, Qingbo Huang, Baojun Wang, Xin Ma, Xu Zhang, Yan Huang
Publikováno v:
Cell Death and Disease, Vol 15, Iss 10, Pp 1-13 (2024)
Abstract Primary cilia are present on renal tubules and are implicated to play a pivotal role in transducing signals during development; however, the oncogenic role of cilia in clear cell renal cell carcinoma (ccRCC) has not been examined. Here we sh
Externí odkaz:
https://doaj.org/article/ae93bf846257454a9ae46c1bf4de6653
Autor:
Liangyou Gu, Cheng Peng, Qiyang Liang, Qingbo Huang, Deqiang Lv, Houming Zhao, Qi Zhang, Yu Zhang, Peng Zhang, Shichao Li, Junnan Xu, Luyao Chen, Yongpeng Xie, Jinhang Li, Gang Guo, Xu Zhang, Baojun Wang, Xin Ma
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 9, Iss 1, Pp 1-9 (2024)
Abstract The potential benefit of neoadjuvant toripalimab plus axitinib in cases with clear cell renal cell carcinoma (ccRCC) and inferior vena cava tumor thrombus (IVC-TT) remains unclear. NEOTAX was a phase 2 study to investigate the efficacy and s
Externí odkaz:
https://doaj.org/article/302c3b05849c4d84a9257697767e9891
Autor:
Ruopeng Su, Tingxuan Huang, Liangyou Gu, Yige Bao, Zhihong Liu, Pinghong Dao, Lin Yao, Xiaoyi Hu, Guanghou Fu, Jitao Wu, Thibault Tricard, Guangyu Wu, Minfeng Chen, Chancan Li, Zhiyang Huang, Bing Zheng, Yonghui Chen, Wei Xue, Gang Guo, Pei Dong, Jiwei Huang, Jin Zhang
Publikováno v:
Cancer Medicine, Vol 13, Iss 17, Pp n/a-n/a (2024)
Abstract Objectives To assess the efficacy and safety of preoperative neoadjuvant everolimus in renal angiomyolipomas (AML) patients with or without Tuberous Sclerosis Complex (TSC). Materials and Methods This multi‐institutional retrospective stud
Externí odkaz:
https://doaj.org/article/d72d1762ebea4d768e0a85bafd895d03
Publikováno v:
The Innovation, Vol 4, Iss 5, Pp 100499- (2023)
Externí odkaz:
https://doaj.org/article/49360630204a430e869d1a0618bb8f97
Autor:
Lisong Shan, Xue Shao, Liangyou Gu, Minhong Wu, Pengxiu Lin, Zhiling Yu, Qingsheng Chen, Daqing Zhu
Publikováno v:
Frontiers in Surgery, Vol 9 (2022)
BackgroundThere are still differences in the prognostic factors of renal cell carcinoma with sarcomatoid dedifferentiation (sRCC). The aim of this study was to evaluate important predictors of survival in patients with sRCC.Patients and methodsA comp
Externí odkaz:
https://doaj.org/article/d41ac75422564e749b87d4bb0a3427de
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 16, Iss 1, Pp 1-8 (2021)
Abstract Background To evaluate the efficacy, safety and health economics of sequential everolimus in treating angiomyolipoma (AML) associated with tuberous sclerosis complex (TSC). Methods In this prospective cohort study, patients met the inclusion
Externí odkaz:
https://doaj.org/article/d12d4d5950924a32925760f53d637ac0
Autor:
Liangyou Gu, Qing Ai, Qiang Cheng, Xin Ma, Baojun Wang, Qingbo Huang, Xintao Li, Peng Zhang, Kan Liu, Xupeng Zhao, Hongzhao Li, Xu Zhang
Publikováno v:
Cancer Cell International, Vol 20, Iss 1, Pp 1-14 (2020)
Abstract Background A systematic review and meta-analysis was performed to compare the clinicopathological features and survival outcomes between sarcomatoid variant (SV)-urothelial carcinoma of the bladder (UCB) and conventional UCB (C-UCB). Methods
Externí odkaz:
https://doaj.org/article/b1fc98e8a83243c3896d1f88f0638bb1
Autor:
Yongpeng Xie, Luyao Chen, Yu Gao, Xin Ma, Weiyang He, Yu Zhang, Fan Zhang, Yang Fan, Liangyou Gu, Pin Li, Xu Zhang, Xin Gou
Publikováno v:
Cancer Cell International, Vol 20, Iss 1, Pp 1-16 (2020)
Abstract Background MicroRNAs (miRNAs) serve as important regulators of the tumorigenesis and progression of many human cancers. Therefore, we evaluated the biological function and underlying mechanism of miR-363 in clear cell renal cell carcinoma (c
Externí odkaz:
https://doaj.org/article/992ca24a8aa44c61acb38ebd9d13f364
Autor:
Liangyou Gu, Wenlei Zhao, Junnan Xu, Baojun Wang, Qiang Cheng, Donglai Shen, Yundong Xuan, Xupeng Zhao, Hongzhao Li, Xin Ma, Xu Zhang
Publikováno v:
Frontiers in Oncology, Vol 11 (2022)
ObjectivesWe compared the outcomes of transperitoneal robotic partial nephrectomy (TRPN) and retroperitoneal robotic partial nephrectomy (RRPN) for complete upper pole renal masses (1 point for the “L” component of the RENAL scoring system).Mater
Externí odkaz:
https://doaj.org/article/6024ebfcb7a34a62b1e2379fe1c70f35
Publikováno v:
Frontiers in Oncology, Vol 10 (2021)
BackgroundTo compare perioperative, functional and oncological outcomes between transperitoneal robotic partial nephrectomy (TRPN) and retroperitoneal robotic partial nephrectomy (RRPN).MethodsA literature searching of Pubmed, Embase, Cochrane Librar
Externí odkaz:
https://doaj.org/article/289cd357362d4fb3a3741bcd89fd49ac